292 related articles for article (PubMed ID: 27995735)
21. Pathological cut-offs of global and regional brain volume loss in multiple sclerosis.
Uher T; Vaneckova M; Krasensky J; Sobisek L; Tyblova M; Volna J; Seidl Z; Bergsland N; Dwyer MG; Zivadinov R; De Stefano N; Sormani MP; Havrdova EK; Horakova D
Mult Scler; 2019 Apr; 25(4):541-553. PubMed ID: 29143562
[TBL] [Abstract][Full Text] [Related]
22. Longitudinal Assessment of Multiple Sclerosis with the Brain-Age Paradigm.
Cole JH; Raffel J; Friede T; Eshaghi A; Brownlee WJ; Chard D; De Stefano N; Enzinger C; Pirpamer L; Filippi M; Gasperini C; Rocca MA; Rovira A; Ruggieri S; Sastre-Garriga J; Stromillo ML; Uitdehaag BMJ; Vrenken H; Barkhof F; Nicholas R; Ciccarelli O;
Ann Neurol; 2020 Jul; 88(1):93-105. PubMed ID: 32285956
[TBL] [Abstract][Full Text] [Related]
23. Callosal lesion predicts future attacks after clinically isolated syndrome.
Jafari N; Kreft KL; Flach HZ; Janssens AC; Hintzen RQ
Neurology; 2009 Dec; 73(22):1837-41. PubMed ID: 19949029
[TBL] [Abstract][Full Text] [Related]
24. Composite MRI measures and short-term disability in patients with clinically isolated syndrome suggestive of MS.
Bommarito G; Bellini A; Pardini M; Solaro C; Roccatagliata L; Laroni A; Capello E; Mancardi GL; Uccelli A; Inglese M
Mult Scler; 2018 Apr; 24(5):623-631. PubMed ID: 28394195
[TBL] [Abstract][Full Text] [Related]
25. Magnetic resonance imaging as a prognostic disability marker in clinically isolated syndrome: A systematic review.
Rahn AC; Köpke S; Stellmann JP; Schiffmann I; Lukas C; Chard D; Heesen C
Acta Neurol Scand; 2019 Jan; 139(1):18-32. PubMed ID: 30091223
[TBL] [Abstract][Full Text] [Related]
26. Corpus callosum demyelination associated with acquired stuttering.
Decker BM; Guitar B; Solomon A
BMJ Case Rep; 2018 Apr; 2018():. PubMed ID: 29680798
[TBL] [Abstract][Full Text] [Related]
27. Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome.
Okuda DT; Mowry EM; Beheshtian A; Waubant E; Baranzini SE; Goodin DS; Hauser SL; Pelletier D
Neurology; 2009 Mar; 72(9):800-5. PubMed ID: 19073949
[TBL] [Abstract][Full Text] [Related]
28. Identification of fibers at risk for degeneration by diffusion tractography in patients at high risk for MS after a clinically isolated syndrome.
Simon JH; Zhang S; Laidlaw DH; Miller DE; Brown M; Corboy J; Bennett J
J Magn Reson Imaging; 2006 Nov; 24(5):983-8. PubMed ID: 17024655
[TBL] [Abstract][Full Text] [Related]
29. Quantitative determination of MS-induced corpus callosum atrophy in vivo using MR imaging.
Simon JH; Schiffer RB; Rudick RA; Herndon RM
AJNR Am J Neuroradiol; 1987; 8(4):599-604. PubMed ID: 3113196
[TBL] [Abstract][Full Text] [Related]
30. Reliability of measuring regional callosal atrophy in neurodegenerative diseases.
Van Schependom J; Jain S; Cambron M; Vanbinst AM; De Mey J; Smeets D; Nagels G
Neuroimage Clin; 2016; 12():825-831. PubMed ID: 27830115
[TBL] [Abstract][Full Text] [Related]
31. Associations Between Findings From Myelin Water Imaging and Cognitive Performance Among Individuals With Multiple Sclerosis.
Abel S; Vavasour I; Lee LE; Johnson P; Ristow S; Ackermans N; Chan J; Cross H; Laule C; Dvorak A; Schabas A; Hernández-Torres E; Tam R; Kuan AJ; Morrow SA; Wilken J; Rauscher A; Bhan V; Sayao AL; Devonshire V; Li DKB; Carruthers R; Traboulsee A; Kolind SH
JAMA Netw Open; 2020 Sep; 3(9):e2014220. PubMed ID: 32990740
[TBL] [Abstract][Full Text] [Related]
32. The corpus callosum in the diagnosis of multiple sclerosis and other CNS demyelinating and inflammatory diseases.
Garg N; Reddel SW; Miller DH; Chataway J; Riminton DS; Barnett Y; Masters L; Barnett MH; Hardy TA
J Neurol Neurosurg Psychiatry; 2015 Dec; 86(12):1374-82. PubMed ID: 25857658
[TBL] [Abstract][Full Text] [Related]
33. Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis.
Cocozza S; Olivo G; Riccio E; Russo C; Pontillo G; Ugga L; Migliaccio S; de Rosa D; Feriozzi S; Veroux M; Battaglia Y; Concolino D; Pieruzzi F; Tuttolomondo A; Caronia A; Russo CV; Lanzillo R; Brescia Morra V; Imbriaco M; Brunetti A; Tedeschi E; Pisani A
Neuroradiology; 2017 Jun; 59(6):563-570. PubMed ID: 28386689
[TBL] [Abstract][Full Text] [Related]
34. Clinical impact of early brain atrophy in clinically isolated syndromes.
Pérez-Miralles F; Sastre-Garriga J; Tintoré M; Arrambide G; Nos C; Perkal H; Río J; Edo MC; Horga A; Castilló J; Auger C; Huerga E; Rovira A; Montalban X
Mult Scler; 2013 Dec; 19(14):1878-86. PubMed ID: 23652215
[TBL] [Abstract][Full Text] [Related]
35. MRI/MRS of corpus callosum in patients with clinically isolated syndrome suggestive of multiple sclerosis.
Ranjeva JP; Pelletier J; Confort-Gouny S; Ibarrola D; Audoin B; Le Fur Y; Viout P; Chérif AA; Cozzone PJ
Mult Scler; 2003 Dec; 9(6):554-65. PubMed ID: 14664467
[TBL] [Abstract][Full Text] [Related]
36. Clinical manifestations in children and adolescents with corpus callosum abnormalities.
Margari L; Palumbi R; Campa MG; Operto FF; Buttiglione M; Craig F; Matricardi S; Verrotti A
J Neurol; 2016 Oct; 263(10):1939-45. PubMed ID: 27383641
[TBL] [Abstract][Full Text] [Related]
37. A prospective, observational study on conversion of clinically isolated syndrome to multiple sclerosis during 4-year period (MS NEO study) in Taiwan.
Ro LS; Yang CC; Lyu RK; Lin KP; Tsai TC; Lu SR; Chang KH; Huang LC; Tsai CP
PLoS One; 2019; 14(7):e0202453. PubMed ID: 31306415
[TBL] [Abstract][Full Text] [Related]
38. The Value of Corpus Callosum Measurement in the Diagnosis of Cerebral Atrophy.
Ji-Ping Z; Chun-Xiao C; Chong-Feng D; Lei N; Xue-Jun L
Curr Med Imaging; 2020; 16(6):682-687. PubMed ID: 32723239
[TBL] [Abstract][Full Text] [Related]
39. Corpus callosum atrophy--a simple predictor of multiple sclerosis progression: a longitudinal 9-year study.
Vaneckova M; Kalincik T; Krasensky J; Horakova D; Havrdova E; Hrebikova T; Seidl Z
Eur Neurol; 2012; 68(1):23-7. PubMed ID: 22677920
[TBL] [Abstract][Full Text] [Related]
40. Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.
Kuhle J; Disanto G; Dobson R; Adiutori R; Bianchi L; Topping J; Bestwick JP; Meier UC; Marta M; Dalla Costa G; Runia T; Evdoshenko E; Lazareva N; Thouvenot E; Iaffaldano P; Direnzo V; Khademi M; Piehl F; Comabella M; Sombekke M; Killestein J; Hegen H; Rauch S; D'Alfonso S; Alvarez-Cermeño JC; Kleinová P; Horáková D; Roesler R; Lauda F; Llufriu S; Avsar T; Uygunoglu U; Altintas A; Saip S; Menge T; Rajda C; Bergamaschi R; Moll N; Khalil M; Marignier R; Dujmovic I; Larsson H; Malmestrom C; Scarpini E; Fenoglio C; Wergeland S; Laroni A; Annibali V; Romano S; Martínez AD; Carra A; Salvetti M; Uccelli A; Torkildsen Ø; Myhr KM; Galimberti D; Rejdak K; Lycke J; Frederiksen JL; Drulovic J; Confavreux C; Brassat D; Enzinger C; Fuchs S; Bosca I; Pelletier J; Picard C; Colombo E; Franciotta D; Derfuss T; Lindberg R; Yaldizli Ö; Vécsei L; Kieseier BC; Hartung HP; Villoslada P; Siva A; Saiz A; Tumani H; Havrdová E; Villar LM; Leone M; Barizzone N; Deisenhammer F; Teunissen C; Montalban X; Tintoré M; Olsson T; Trojano M; Lehmann S; Castelnovo G; Lapin S; Hintzen R; Kappos L; Furlan R; Martinelli V; Comi G; Ramagopalan SV; Giovannoni G
Mult Scler; 2015 Jul; 21(8):1013-24. PubMed ID: 25680984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
